Whole body leucine, phenylalanine, and tyrosine kinetics in end-stage liver disease before and after hepatic transplantation
β Scribed by Ragu L.K. Shanbhogue; Bruce R. Bistrian; Krish Lakshman; Lisa Crosby; Scott Swenson; David Wagner; Roger L. Jenkins; George L. Blackburn
- Book ID
- 118949342
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 902 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1532-8600
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of end-stage liver disease (ESLD) on sexual functioning are complex and often overlooked in the context of chronic illness and the transplantation evaluation. The aim of the present study is to report on the prevalence of sexual dysfunction in patients with ESLD presenting for liver tran
It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo